Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 19,616 shares at $33.37 ($655K) on 2016-10-07, disclosed to the SEC on 2016-10-11.
Open-market sale of $655k XLRN by SVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XLRN | SELL | 2019-01-04 | $232K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $176K | — | Filing → |